Cargando…
Accessing Mefenamic Acid Form II through High-Pressure Recrystallisation
High-pressure crystallisation has been successfully used as an alternative technique to prepare Form II of a non-steroidal anti-inflammatory drug, mefenamic acid (MA). A single crystal of Form II, denoted as high-pressure Form II, was grown at 0.3 GPa from an ethanolic solution by using a diamond an...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489933/ https://www.ncbi.nlm.nih.gov/pubmed/28509850 http://dx.doi.org/10.3390/pharmaceutics9020016 |
_version_ | 1783246882497101824 |
---|---|
author | Abbas, Nasir Oswald, Iain D. H. Pulham, Colin R. |
author_facet | Abbas, Nasir Oswald, Iain D. H. Pulham, Colin R. |
author_sort | Abbas, Nasir |
collection | PubMed |
description | High-pressure crystallisation has been successfully used as an alternative technique to prepare Form II of a non-steroidal anti-inflammatory drug, mefenamic acid (MA). A single crystal of Form II, denoted as high-pressure Form II, was grown at 0.3 GPa from an ethanolic solution by using a diamond anvil cell. A comparison of the crystal structures shows that the efficient packing of molecules in Form II was enabled by the structural flexibility of MA molecules. Compression studies performed on a single crystal of Form I resulted in a 14% decrease of unit cell volume up to 2.5 GPa. No phase transition was observed up to this pressure. A reconstructive phase transition is required to induce conformational changes in the structure, which was confirmed by the results of crystallisation at high pressure. |
format | Online Article Text |
id | pubmed-5489933 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-54899332017-06-30 Accessing Mefenamic Acid Form II through High-Pressure Recrystallisation Abbas, Nasir Oswald, Iain D. H. Pulham, Colin R. Pharmaceutics Article High-pressure crystallisation has been successfully used as an alternative technique to prepare Form II of a non-steroidal anti-inflammatory drug, mefenamic acid (MA). A single crystal of Form II, denoted as high-pressure Form II, was grown at 0.3 GPa from an ethanolic solution by using a diamond anvil cell. A comparison of the crystal structures shows that the efficient packing of molecules in Form II was enabled by the structural flexibility of MA molecules. Compression studies performed on a single crystal of Form I resulted in a 14% decrease of unit cell volume up to 2.5 GPa. No phase transition was observed up to this pressure. A reconstructive phase transition is required to induce conformational changes in the structure, which was confirmed by the results of crystallisation at high pressure. MDPI 2017-05-16 /pmc/articles/PMC5489933/ /pubmed/28509850 http://dx.doi.org/10.3390/pharmaceutics9020016 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Abbas, Nasir Oswald, Iain D. H. Pulham, Colin R. Accessing Mefenamic Acid Form II through High-Pressure Recrystallisation |
title | Accessing Mefenamic Acid Form II through High-Pressure Recrystallisation |
title_full | Accessing Mefenamic Acid Form II through High-Pressure Recrystallisation |
title_fullStr | Accessing Mefenamic Acid Form II through High-Pressure Recrystallisation |
title_full_unstemmed | Accessing Mefenamic Acid Form II through High-Pressure Recrystallisation |
title_short | Accessing Mefenamic Acid Form II through High-Pressure Recrystallisation |
title_sort | accessing mefenamic acid form ii through high-pressure recrystallisation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489933/ https://www.ncbi.nlm.nih.gov/pubmed/28509850 http://dx.doi.org/10.3390/pharmaceutics9020016 |
work_keys_str_mv | AT abbasnasir accessingmefenamicacidformiithroughhighpressurerecrystallisation AT oswaldiaindh accessingmefenamicacidformiithroughhighpressurerecrystallisation AT pulhamcolinr accessingmefenamicacidformiithroughhighpressurerecrystallisation |